News

Printer Friendly Version View printer-friendly version
<< Back
Array CEO Robert E. Conway to Speak at Needham & Company Biotechnology Conference

BOULDER, Colo., May 22 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Needham & Company Second Annual Biotechnology Conference on June 5 in New York City. The public is welcome to listen to the presentation through an audio webcast on the Array BioPharma website.

     Event:            Needham & Company Second Annual Biotechnology
                        Conference
     Presentation by:  Robert E. Conway, Chief Executive Officer,
                        Array BioPharma
     Date:             Thursday, June 5, 2003
     Time:             2:30 p.m. Eastern Time
     Location:         New York Palace Hotel, NYC
     Audio Webcast:    www.arraybiopharma.com

About Array BioPharma:

Array BioPharma is a drug discovery company creating new small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists use our integrated set of drug discovery technologies, which we call the Array Discovery Platform, to invent small molecule drugs in collaboration with leading pharmaceutical and biotechnology companies and to build our own pipeline of proprietary drug candidates. For more information on Array BioPharma, please visit our web site at www.arraybiopharma.com .

SOURCE Array BioPharma Inc.

-0- 05/22/2003

/CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, thaugeto@arraybiopharma.com/

/Web site: http://www.arraybiopharma.com / (ARRY)

http://www.prnewswire.com